1 / 30

TOC - Global Digital Biomarkers Market

The global digital biomarkers market report highlights that the market was valued at $1,808.3 million in 2021 and is expected to reach $16,174.0 million by 2028. The market is expected to grow at a CAGR of 36.06% during the forecast period 2022-2028.

bisreports
Download Presentation

TOC - Global Digital Biomarkers Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A` Global Digital Biomarkers Market - A Global and Regional Analysis Table of Content https://www.shutterstock.com/image-photo/mri-image-head-showing-brain-227580421 Focus on System Component, Type, Application, End User, Regional and Country-Wise Analysis Analysis and Forecast:2022-2028 April 2022 All rights reserved at BIS Research Inc. 1

  2. BIS Research is a leading market intelligence and technology research company. BIS Research publishes in-depth market intelligence reports focusing on market estimations, technology analysis, emerging high- growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision making for senior management. BIS Research provides multi- client reports, company profiles, databases, and custom research services. Copyright © 2022 BIS Research Inc. All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all contents of this document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered, whether for sale or otherwise, to any third party. All rights reserved at BIS Research Inc. 2

  3. Table of Content Executive Summary .................................................................................... 30 Scope of the Study ..................................................................................... 39 Research Methodology .............................................................................. 41 1. Markets ................................................................................................. 47 1.1 Market Outlook ................................................................................................. 47 1.1.1Product Definition ....................................................................................... 47 1.1.1.1 Data Collection Tools ......................................................................................... 47 1.1.1.1.1 Wearable Devices ................................................................................................... 47 1.1.1.1.2Implantables ............................................................................................................ 47 1.1.1.1.3Mobile Applications ................................................................................................ 48 1.1.1.2 Data Integration Software .................................................................................. 48 1.1.2Inclusion and Exclusion Criteria ................................................................ 48 1.1.3Key Findings ................................................................................................ 49 1.1.4Global Market Scenario ............................................................................... 49 1.1.4.1 Realistic Growth Scenario ................................................................................. 49 1.1.4.2 Optimistic Growth Scenario ............................................................................... 50 1.1.4.3 Pessimistic/Conservative Growth Scenario ....................................................... 51 1.2 Global Digital Biomarkers Market Overview .................................................. 52 1.2.1Current State of Digital Biomarker ............................................................. 52 1.2.2Types of Biomarkers ................................................................................... 53 1.2.2.1 Wellness ............................................................................................................ 53 1.2.2.2 Disease .............................................................................................................. 53 1.2.2.3 Drugs ................................................................................................................. 53 1.2.3Industry ........................................................................................................ 54 1.2.3.1 Pharmaceutical .................................................................................................. 54 1.2.3.2 Biotechnology/Life Sciences .............................................................................. 54 1.2.3.3 Medical Devices ................................................................................................. 55 1.2.3.4 Application Vendors ........................................................................................... 55 1.2.4Clinical Trials (Clinical Research Organization) ....................................... 55 All rights reserved at BIS Research Inc. 3

  4. 1.2.4.1 Technology Vendors .......................................................................................... 56 1.2.5Digital Biomarker Ecosystem ..................................................................... 56 1.2.5.1 Wearable Devices .............................................................................................. 57 1.2.5.2 Implantable Components/ Sensors .................................................................... 59 1.2.5.3 Ocular Devices .................................................................................................. 59 1.2.5.4 Accelerometers .................................................................................................. 60 1.2.5.5 Smart Home Systems/IoTs ................................................................................ 60 1.2.5.6 AR/VR Platforms ................................................................................................ 60 1.2.5.7 Desktop/Web Applications ................................................................................. 61 1.2.6Data Measurement ....................................................................................... 61 1.2.6.1 Physiological Parameters .................................................................................. 61 1.2.6.2 Behavioral Parameters ...................................................................................... 61 1.3 Industry Outlook .............................................................................................. 62 1.3.1Technology Landscape ............................................................................... 62 1.3.1.1 Artificial Intelligence and Machine Learning ...................................................... 62 1.3.1.2 Augmented Reality (AR) and Virtual Reality (VR) ............................................. 63 1.3.1.3 Blockchain ......................................................................................................... 63 1.3.1.4 Edge Computing ................................................................................................ 64 1.3.1.5 Cloud Computing ............................................................................................... 64 1.3.2Key Trends ................................................................................................... 65 1.3.3Opportunity Assessment ............................................................................ 66 1.3.3.1 Short-Term Growth Potential ............................................................................. 66 1.3.3.2 Long-Term Growth Potential .............................................................................. 67 1.3.4Product Benchmarking ............................................................................... 67 1.3.5Patent Analysis ............................................................................................ 68 1.3.5.1 Awaited Technological Developments ............................................................... 68 1.3.5.2 Patent Publication Growth Trend ....................................................................... 69 1.3.5.3 Patent Analysis (by Country/Cluster) ................................................................. 70 1.3.6Case Studies: Key Therapeutic Areas ....................................................... 70 1.3.6.1 Cardiovascular Diseases ................................................................................... 70 All rights reserved at BIS Research Inc. 4

  5. 1.3.6.2 Parkinson’s Diseases ........................................................................................ 71 1.3.6.3 Alzheimer’s Diseases ........................................................................................ 72 1.4 Impact of COVID-19 ......................................................................................... 72 1.4.1Impact on Digital Biomarkers ..................................................................... 72 1.4.2Impact on Device Adoption ........................................................................ 74 1.4.3Impact on Market Size ................................................................................. 77 1.4.3.1 Pre-COVID-19 Phase ........................................................................................ 77 1.4.3.1.1Global and Regional Analysis .................................................................................. 77 1.4.3.2 During COVID-19 Phase ................................................................................... 79 1.4.3.2.1Global and Regional Analysis .................................................................................. 79 1.4.3.3 Post-COVID-19 Phase ....................................................................................... 81 1.5 Business Dynamics ......................................................................................... 81 1.5.1Impact Analysis ........................................................................................... 81 1.5.2Business Drivers ......................................................................................... 82 1.5.2.1 Rising Popularity of Digital Biomarkers in Drug Development ........................... 82 1.5.2.2 Rising Employment of Vocal Digital Biomarkers ................................................ 83 1.5.2.3 Rising Use of Wearable Devices and Increasing Smartphone Penetration ....... 83 1.5.2.4 Regulatory Flexibility toward Digital Health Solutions ........................................ 85 1.5.2.5 Failure of Drugs for Neurodegenerative Disorders ............................................ 85 1.5.3Business Challenges .................................................................................. 86 1.5.3.1 Need for Standardized and Interoperable Solutions .......................................... 86 1.5.3.2 Inaccuracy in Data Measurements .................................................................... 88 1.5.3.3 Lack of Integration and Interoperability between Medical Records and User Generated Data ......................................................................................... 88 1.5.3.4 Lack of Use Cases of the Return on Investment (ROI) Analysis ....................... 88 1.5.4Business Opportunities .............................................................................. 89 1.5.4.1 Digital Biomarkers: The Future of Precision Medicine ....................................... 89 1.5.4.2 Early Detection of Neurological Disorders Using Digital Biomarkers ................. 89 1.5.4.3 Increasing Awareness for General Health Management ................................... 90 1.5.4.4 Upsurge in Demand of Metabolic, Cardiovascular, and Gastrointestinal Healthcare ......................................................................................................... 90 All rights reserved at BIS Research Inc. 5

  6. 1.5.4.5 Penetration of Digital Biomarkers in Female, Maternal, Pre- and Neo- Natal Care .......................................................................................................... 91 1.5.4.6 Rise in Usage of Digital Biomarkers to Assess Pulmonary Health .................... 92 2. Global Digital Biomarker Market (by Application) ............................ 93 2.1 Opportunity Assessment ................................................................................ 93 2.2 Growth-Share Matrix ....................................................................................... 95 2.3 Gastrointestinal Diseases ............................................................................... 96 2.4 Sleep and Movement Disorders ................................................................... 100 2.5 Cardiovascular ............................................................................................... 102 2.6 Psychiatric Disorders (Mood and Behavior) ............................................... 105 2.7 Chronic Pain ................................................................................................... 107 2.8 Neurodegenerative Diseases ........................................................................ 109 2.9 Diabetes .......................................................................................................... 112 2.10Respiratory Diseases .................................................................................... 114 2.11Others ............................................................................................................. 116 3. Global Digital Biomarkers Market (by End User) ............................ 117 3.1 Opportunity Assessment .............................................................................. 117 3.2 Growth-Share Matrix ..................................................................................... 118 3.3 Biopharmaceutical Companies .................................................................... 119 3.4 Payers ............................................................................................................. 120 3.5 Providers ........................................................................................................ 121 Global Digital Biomarkers Market (by System Components) ........ 123 4. 4.1 Opportunity Assessment .............................................................................. 123 4.2 Market Share Analysis .................................................................................. 124 4.3 Growth-Share Matrix ..................................................................................... 125 4.4 Data Collection Tools .................................................................................... 126 4.4.1Wearables Devices .................................................................................... 126 4.4.1.1 Evolution of Wearable Devices in Clinical Trials .............................................. 128 4.4.1.2 Wearable Devices in Clinical Trials ................................................................. 128 4.4.1.3 Actigraphy Devices .......................................................................................... 129 All rights reserved at BIS Research Inc. 6

  7. 4.4.1.4 Opportunity in Digital Biomarker ...................................................................... 130 4.4.1.5 New Developments .......................................................................................... 131 4.4.1.6 Market Estimation and Forecast ...................................................................... 131 4.4.2Implantables .............................................................................................. 132 4.4.2.1 Opportunity in Digital Biomarker ...................................................................... 132 4.4.2.2 New Developments .......................................................................................... 132 4.4.2.3 Market Estimation and Forecast ...................................................................... 133 4.4.3Mobile Applications ................................................................................... 134 4.4.3.1 Opportunity in Digital Biomarkers .................................................................... 135 4.4.3.2 New Developments .......................................................................................... 136 4.4.3.3 Market Estimation and Forecast ...................................................................... 136 4.5 Data Integration Software ............................................................................. 137 4.5.1Opportunity in Digital Biomarker ............................................................. 139 4.5.2New Developments .................................................................................... 139 4.5.3Market Estimation and Forecast .............................................................. 139 Global Digital Biomarkers Market (by Type) ................................... 140 5. 5.1 Opportunity Assessment .............................................................................. 140 5.2 Market Share Analysis .................................................................................. 141 5.3 Growth-Share Matrix ..................................................................................... 142 5.4 Clinical Trials ................................................................................................. 143 5.5 Clinical Settings ............................................................................................. 144 Region ................................................................................................ 145 6. 6.1 North America Digital Biomarkers Market ................................................... 145 6.1.1Regulatory Framework .............................................................................. 145 6.1.2Opportunity Assessment .......................................................................... 146 6.1.3Market Dynamics ....................................................................................... 146 6.1.3.1 Impact Analysis ................................................................................................ 147 6.1.4Sizing and Forecast Analysis ................................................................... 147 6.1.4.1 North America Digital Biomarkers Market (by Application) .............................. 148 6.1.4.2 North America Digital Biomarkers Market (by Type) ....................................... 149 All rights reserved at BIS Research Inc. 7

  8. 6.1.5North America Digital Biomarkers Market (by Country) ........................ 150 6.1.5.1 U.S. .................................................................................................................. 150 6.1.5.1.1Digital Health Scenario .......................................................................................... 150 6.1.5.1.2Degree of Adoption of Wearables .......................................................................... 150 6.1.5.1.3Degree of Adoption of Mobile Health Applications ................................................ 151 6.1.5.1.4Local Players in the Digital Biomarker Market ....................................................... 151 6.1.5.1.5U.S. Digital Biomarkers Market .............................................................................. 151 6.1.5.1.6U.S. Digital Biomarkers Market (by Type) ............................................................. 152 6.1.5.1.7U.S. Digital Biomarkers Market (by Application) .................................................... 153 6.1.5.2 Canada ............................................................................................................ 153 6.1.5.2.1Digital Health Scenario .......................................................................................... 153 6.1.5.2.2Degree of Adoption of Wearables .......................................................................... 154 6.1.5.2.3Degree of Adoption of Mobile Health Applications ................................................ 154 6.1.5.2.4Local Players in the Digital Biomarker Market ....................................................... 155 6.1.5.2.5Canada Digital Biomarkers Market ........................................................................ 155 6.1.5.2.6Canada Digital Biomarkers Market (by Type) ........................................................ 156 6.1.5.2.7Canada Digital Biomarkers Market (by Application) .............................................. 156 6.2 Europe Digital Biomarkers Market ............................................................... 157 6.2.1Regulatory Framework .............................................................................. 157 6.2.2Opportunity Assessment .......................................................................... 158 6.2.3Market Dynamics ....................................................................................... 159 6.2.3.1 Impact Analysis ................................................................................................ 160 6.2.4Sizing and Forecast Analysis ................................................................... 160 6.2.4.1 Europe Digital Biomarkers Market (by Application) ......................................... 161 6.2.4.2 Europe Digital Biomarkers Market (by Type) ................................................... 162 6.2.5Europe Digital Biomarkers Market (by Country) ..................................... 163 6.2.5.1 Netherlands ..................................................................................................... 163 6.2.5.1.1Digital Health Scenario .......................................................................................... 163 6.2.5.1.2Degree of Adoption of Wearables .......................................................................... 163 6.2.5.1.3Degree of Adoption of Mobile Health Applications ................................................ 163 All rights reserved at BIS Research Inc. 8

  9. 6.2.5.1.4Local Players in the Digital Biomarker Market ....................................................... 164 6.2.5.1.5Netherlands Digital Biomarkers Market ................................................................. 164 6.2.5.1.6Netherlands Digital Biomarkers Market (by Type) ................................................. 165 6.2.5.1.7Netherlands Digital Biomarkers Market (by Application) ....................................... 165 6.2.5.2 Germany .......................................................................................................... 166 6.2.5.2.1Digital Health Scenario .......................................................................................... 166 6.2.5.2.2Degree of Adoption of Wearables .......................................................................... 166 6.2.5.2.3Reluctance to Fitness Trackers ............................................................................. 167 6.2.5.2.4Future of Digital Health in Germany ....................................................................... 167 6.2.5.2.5Germany Digital Biomarkers Market ...................................................................... 168 6.2.5.2.6Germany Digital Biomarkers Market (by Type) ...................................................... 168 6.2.5.2.7Germany Digital Biomarkers Market (by Application) ............................................ 169 6.2.5.3 France .............................................................................................................. 170 6.2.5.3.1Digital Health Scenario .......................................................................................... 170 6.2.5.3.2Degree of Adoption of Wearables .......................................................................... 170 6.2.5.3.3Local Players in Digital Biomarkers Market ........................................................... 170 6.2.5.3.4France Digital Biomarkers Market .......................................................................... 171 6.2.5.3.5France Digital Biomarkers Market (by Type) ......................................................... 171 6.2.5.3.6France Digital Biomarkers Market (by Application) ................................................ 172 6.2.5.4 Italy .................................................................................................................. 173 6.2.5.4.1Digital Health Scenario .......................................................................................... 173 6.2.5.4.2Degree of Adoption of Wearables .......................................................................... 173 6.2.5.4.3Italy Digital Biomarkers Market .............................................................................. 174 6.2.5.4.4Italy Digital Biomarkers Market (by Type) .............................................................. 174 6.2.5.4.5Italy Digital Biomarkers Market (by Application) .................................................... 175 6.2.5.5 Spain ................................................................................................................ 176 6.2.5.5.1Digital Health Scenario .......................................................................................... 176 6.2.5.5.2Degree of Adoption of Wearables .......................................................................... 176 6.2.5.5.3Spain Digital Biomarkers Market ............................................................................ 176 6.2.5.5.4Spain Digital Biomarkers Market (by Type) ........................................................... 177 All rights reserved at BIS Research Inc. 9

  10. 6.2.5.5.5Spain Digital Biomarkers Market (by Application) .................................................. 178 6.2.5.6 Russia .............................................................................................................. 178 6.2.5.6.1Digital Health Scenario .......................................................................................... 178 6.2.5.6.2Degree of Adoption of Wearables .......................................................................... 179 6.2.5.6.3Degree of Adoption of Mobile Health Applications ................................................ 179 6.2.5.6.4Russia Digital Biomarkers Market .......................................................................... 179 6.2.5.6.5Russia Digital Biomarkers Market (by Type) ......................................................... 180 6.2.5.6.6Russia Digital Biomarkers Market (by Application) ................................................ 181 6.2.5.7 U.K. .................................................................................................................. 181 6.2.5.7.1Digital Health Scenario .......................................................................................... 181 6.2.5.7.2Degree of Adoption of Wearables .......................................................................... 182 6.2.5.7.3Increasing Sales of Smartwatches ......................................................................... 182 6.2.5.7.4Abandonment of Wearables .................................................................................. 182 6.2.5.7.5Local Players in Digital Biomarkers ....................................................................... 182 6.2.5.7.6U.K. Digital Biomarkers Market .............................................................................. 183 6.2.5.7.7U.K. Digital Biomarkers Market (by Type) ............................................................. 183 6.2.5.7.8U.K. Digital Biomarkers Market (by Application) .................................................... 184 6.2.5.8 Rest-of-Europe ................................................................................................ 185 6.2.5.8.1Digital Health Scenario .......................................................................................... 185 6.2.5.8.2Degree of Adoption of Wearables .......................................................................... 185 6.2.5.8.3Increasing Sales of Smartwatches ......................................................................... 185 6.2.5.8.4Local Players in Digital Biomarkers ....................................................................... 186 6.2.5.8.5Rest-of-Europe Digital Biomarkers Market ............................................................ 186 6.2.5.8.6Rest-of-Europe Digital Biomarkers Market (by Type) ............................................ 186 6.2.5.8.7Rest-of-Europe Digital Biomarkers Market (by Application) .................................. 187 6.3 Asia-Pacific Digital Biomarkers Market ....................................................... 188 6.3.1Regulatory Framework .............................................................................. 188 6.3.2Opportunity Assessment .......................................................................... 189 6.3.3Market Dynamics ....................................................................................... 190 6.3.3.1 Impact Analysis ................................................................................................ 190 All rights reserved at BIS Research Inc. 10

  11. 6.3.4Sizing and Forecast Analysis ................................................................... 191 6.3.4.1 Asia-Pacific Digital Biomarkers Market (by Application) .................................. 191 6.3.4.2 Asia-Pacific Digital Biomarkers Market (by Type) ............................................ 192 6.3.5Asia-Pacific Digital Biomarkers Market (by Country) ............................. 193 6.3.5.1 Singapore ........................................................................................................ 193 6.3.5.1.1Digital Health Scenario .......................................................................................... 193 6.3.5.1.2Degree of Adoption of Wearables .......................................................................... 193 6.3.5.1.3Degree of Adoption of Mobile Health ..................................................................... 193 6.3.5.1.4Singapore Digital Biomarkers Market .................................................................... 193 6.3.5.1.5Singapore Digital Biomarkers Market (by Type) .................................................... 194 6.3.5.1.6Singapore Digital Biomarkers Market (by Application) .......................................... 195 6.3.5.2 Australia ........................................................................................................... 195 6.3.5.2.1Digital Health Scenario .......................................................................................... 195 6.3.5.2.2Degree of Adoption of Wearables .......................................................................... 196 6.3.5.2.3Degree of Adoption of Mobile Health ..................................................................... 196 6.3.5.2.4Australia Digital Biomarkers Market ....................................................................... 197 6.3.5.2.5Australia Digital Biomarkers Market (by Type) ...................................................... 197 6.3.5.2.6Australia Digital Biomarkers Market (by Application) ............................................. 198 6.3.5.3 India ................................................................................................................. 199 6.3.5.3.1Digital Health Scenario .......................................................................................... 199 6.3.5.3.2Degree of Adoption of Wearables .......................................................................... 199 6.3.5.3.3Degree of Adoption of Mobile Health ..................................................................... 200 6.3.5.3.4India Digital Biomarkers Market ............................................................................. 200 6.3.5.3.5India Digital Biomarkers Market (by Type) ............................................................. 201 6.3.5.3.6India Digital Biomarkers Market (by Application) ................................................... 202 6.3.5.4 South Korea ..................................................................................................... 202 6.3.5.4.1Digital Health Scenario .......................................................................................... 202 6.3.5.4.2Degree of Adoption of Wearables .......................................................................... 203 6.3.5.4.3Degree of Adoption of Mobile Health ..................................................................... 203 6.3.5.4.4South Korea Digital Biomarkers Market ................................................................. 203 All rights reserved at BIS Research Inc. 11

  12. 6.3.5.4.5South Korea Digital Biomarkers Market (by Type) ................................................ 204 6.3.5.4.6South Korea Digital Biomarkers Market (by Application) ....................................... 205 6.3.5.5 Japan ............................................................................................................... 205 6.3.5.5.1Digital Health Scenario .......................................................................................... 205 6.3.5.5.2Degree of Adoption of Wearables .......................................................................... 206 6.3.5.5.3Degree of Adoption of Mobile Health ..................................................................... 206 6.3.5.5.4Japan Digital Biomarkers Market ........................................................................... 206 6.3.5.5.5Japan Digital Biomarkers Market (by Type) ........................................................... 207 6.3.5.5.6Japan Digital Biomarkers Market (by Application) ................................................. 208 6.3.5.6 China ............................................................................................................... 208 6.3.5.6.1Digital Health Scenario .......................................................................................... 208 6.3.5.6.2Degree of Adoption of Wearables .......................................................................... 209 6.3.5.6.3Degree of Adoption of Mobile Health ..................................................................... 209 6.3.5.6.4Local Players in Digital Biomarker Market ............................................................. 210 6.3.5.6.5China Digital Biomarkers Market ........................................................................... 210 6.3.5.6.6China Digital Biomarkers Market (by Type) ........................................................... 211 6.3.5.6.7China Digital Biomarkers Market (by Application) ................................................. 211 6.3.5.7 Rest-of-Asia-Pacific ......................................................................................... 212 6.3.5.7.1Digital Health Scenario .......................................................................................... 212 6.3.5.7.2Degree of Adoption of Wearables .......................................................................... 212 6.3.5.7.3Degree of Adoption of Mobile Health Applications ................................................ 213 6.3.5.7.4Rest-of-Asia-Pacific Digital Biomarkers Market ..................................................... 213 6.3.5.7.5Rest-of-Asia-Pacific Digital Biomarkers Market (by Type) ..................................... 214 6.3.5.7.6Rest-of-Asia-Pacific Digital Biomarkers Market (by Application) ........................... 214 6.4 Latin America Digital Biomarkers Market .................................................... 215 6.4.1Regulatory Framework .............................................................................. 215 6.4.2Opportunity Assessment .......................................................................... 216 6.4.3Market Dynamics ....................................................................................... 216 6.4.3.1 Impact Analysis ................................................................................................ 217 6.4.4Sizing and Forecast Analysis ................................................................... 217 All rights reserved at BIS Research Inc. 12

  13. 6.4.4.1 Latin America Digital Biomarkers Market (by Application) ............................... 218 6.4.4.2 Latin America Digital Biomarkers Market (by Type) ........................................ 219 6.4.5Latin America Digital Biomarkers Market (by Country) ......................... 220 6.4.5.1 Brazil ................................................................................................................ 220 6.4.5.1.1Digital Health Scenario .......................................................................................... 220 6.4.5.1.2Degree of Adoption of Mobile Health Applications ................................................ 220 6.4.5.1.3Brazil Digital Biomarkers Market ............................................................................ 221 6.4.5.1.4Brazil Digital Biomarkers Market (by Type) ........................................................... 221 6.4.5.1.5Brazil Digital Biomarkers Market (by Application) .................................................. 222 6.4.5.2 Mexico ............................................................................................................. 223 6.4.5.2.1Digital Health Scenario .......................................................................................... 223 6.4.5.2.2Degree of Adoption of Mobile Health Applications ................................................ 223 6.4.5.2.3Mexico Digital Biomarkers Market ......................................................................... 224 6.4.5.2.4Mexico Digital Biomarkers Market (by Type) ......................................................... 224 6.4.5.2.5Mexico Digital Biomarkers Market (by Application) ............................................... 225 6.4.5.3 Rest-of-Latin America ...................................................................................... 226 6.4.5.3.1Digital Health Scenario .......................................................................................... 226 6.4.5.3.2Degree of Adoption of Wearables .......................................................................... 226 6.4.5.3.3Degree of Adoption of Mobile Health ..................................................................... 226 6.4.5.3.4Rest-of-Latin America Digital Biomarkers Market .................................................. 227 6.4.5.3.5Rest-of-Latin America Digital Biomarkers Market (by Type) ................................. 228 6.4.5.3.6Rest-of-Latin America Digital Biomarkers Market (by Application) ........................ 228 6.5 Rest-of-the-World .......................................................................................... 229 6.5.1Regulatory Framework .............................................................................. 229 6.5.2Opportunity Assessment .......................................................................... 230 6.5.3Market Dynamics ....................................................................................... 230 6.5.3.1 Impact Analysis ................................................................................................ 231 6.5.4Sizing and Forecast Analysis ................................................................... 231 6.5.4.1 Rest-of-the-World Digital Biomarkers Market (by Application) ........................ 232 6.5.4.2 Rest-of-the-World Digital Biomarkers Market (by Type) .................................. 233 All rights reserved at BIS Research Inc. 13

  14. 6.5.5Rest-of-the-World Digital Biomarkers Market (by Country) ................... 234 6.5.5.1 Saudi Arabia .................................................................................................... 234 6.5.5.1.1Digital Health Scenario .......................................................................................... 234 6.5.5.1.2Degree of Adoption of Wearables .......................................................................... 234 6.5.5.1.3Degree of Adoption of Mobile Health Applications ................................................ 234 6.5.5.1.4Saudi Arabia Digital Biomarkers Market ................................................................ 235 6.5.5.1.5Saudi Arabia Digital Biomarkers Market (by Type) ................................................ 235 6.5.5.1.6Saudi Arabia Digital Biomarkers Market (by Application) ...................................... 236 6.5.5.2 U.A.E ............................................................................................................... 237 6.5.5.2.1Digital Health Scenario .......................................................................................... 237 6.5.5.2.2Degree of Adoption of Wearables .......................................................................... 237 6.5.5.2.3Degree of Adoption of Mobile Health Applications ................................................ 237 6.5.5.2.4U.A.E. Digital Biomarkers Market .......................................................................... 237 6.5.5.2.5U.A.E. Digital Biomarkers Market (by Type) .......................................................... 238 6.5.5.2.6U.A.E. Digital Biomarkers Market (by Application) ................................................ 239 6.5.5.3 Israel ................................................................................................................ 239 6.5.5.3.1Digital Health Scenario .......................................................................................... 239 6.5.5.3.2Degree of Adoption of Wearables .......................................................................... 240 6.5.5.3.3Degree of Adoption of Mobile Health Applications ................................................ 240 6.5.5.3.4Israel Digital Biomarkers Market ............................................................................ 240 6.5.5.3.5Israel Digital Biomarkers Market (by Type) ............................................................ 241 6.5.5.3.6Israel Digital Biomarkers Market (by Application) .................................................. 241 6.5.5.4 South Africa ..................................................................................................... 242 6.5.5.4.1Digital Health Scenario .......................................................................................... 242 6.5.5.4.2Degree of Adoption of Wearables .......................................................................... 242 6.5.5.4.3Degree of Adoption of Mobile Health Applications ................................................ 243 6.5.5.4.4South Africa Digital Biomarkers Market ................................................................. 243 6.5.5.4.5South Africa Digital Biomarkers Market (by Type) ................................................. 244 6.5.5.4.6South Africa Digital Biomarkers Market (by Application) ....................................... 244 6.5.5.5 Rest-of-Rest-of-the-World ................................................................................ 245 All rights reserved at BIS Research Inc. 14

  15. 6.5.5.5.1Digital Health Scenario .......................................................................................... 245 6.5.5.5.2Degree of Adoption of Wearables .......................................................................... 245 6.5.5.5.3Degree of Adoption of Mobile Health Applications ................................................ 245 6.5.5.5.4Rest-of-Rest-of -the-World Digital Biomarkers Market .......................................... 246 6.5.5.5.5Rest-of-Rest-of-the-World Digital Biomarkers Market (by Type) ........................... 247 6.5.5.5.6Rest-of-Rest-of-the-World Digital Biomarkers Market (by Application) ................. 247 7. Market- Company Profiles and Competitive Benchmarking ......... 249 7.1 Competitive Landscape ................................................................................ 249 7.1.1Key Strategies and Developments ........................................................... 249 7.1.1.1 Partnerships, Alliances, and Business Expansions ......................................... 250 7.1.1.2 Funding Activities ............................................................................................. 251 7.1.1.2.1New Offerings ........................................................................................................ 251 7.1.1.2.2Mergers and Acquisitions ....................................................................................... 252 7.1.1.2.3Regulatory and Legal Activities .............................................................................. 253 7.2 Company Profiles .......................................................................................... 254 7.2.1Established Companies ............................................................................ 254 7.2.1.1 Alphabet Inc. .................................................................................................... 254 7.2.1.1.1Company Overview ................................................................................................ 254 7.2.1.1.2Role of Alphabet Inc. in the Global Digital Biomarkers Market .............................. 254 7.2.1.1.3Product Portfolio and Offerings .............................................................................. 255 7.2.1.1.4Financials ............................................................................................................... 256 7.2.1.1.4.1Recent Developments .................................................................................... 257 7.2.1.1.5SWOT Analysis ...................................................................................................... 259 7.2.1.2 AliveCor Inc. .................................................................................................... 260 7.2.1.2.1Company Overview ................................................................................................ 260 7.2.1.2.2Role of AliveCor, Inc. in the Global Digital Biomarkers Market ............................. 260 7.2.1.2.3Product Portfolio and Offerings .............................................................................. 260 7.2.1.2.4Recent Development ............................................................................................. 261 7.2.1.2.5SWOT Analysis ...................................................................................................... 262 7.2.1.3 Akili Interactive Labs, Inc. ................................................................................ 263 All rights reserved at BIS Research Inc. 15

  16. 7.2.1.3.1Company Overview ................................................................................................ 263 7.2.1.3.2Role of Akili Interactive Labs in the Global Digital Biomarkers Market .................. 263 7.2.1.3.3Product Portfolio and Offerings .............................................................................. 263 7.2.1.3.3.1.1Recent Developments ........................................................................................... 264 7.2.1.3.3.1.2SWOT Analysis ..................................................................................................... 264 7.2.1.4 Cambridge Cognition Ltd ................................................................................. 265 7.2.1.4.1Company Overview ................................................................................................ 265 7.2.1.4.2Role of Cambridge Cognition Ltd in the Global Digital Biomarkers Market ........... 265 7.2.1.4.3Product Portfolio and Offerings .............................................................................. 265 7.2.1.4.4Financials ............................................................................................................... 266 7.2.1.4.5Recent Developments ............................................................................................ 268 7.2.1.4.6SWOT Analysis ...................................................................................................... 269 7.2.1.5 Dassault Systèmes .......................................................................................... 270 7.2.1.5.1Company Overview ................................................................................................ 270 7.2.1.5.2Role of Dassault Systèmes in the Global Digital Biomarkers Market .................... 270 7.2.1.5.3Product Portfolio and Offerings .............................................................................. 271 7.2.1.5.4Financials ............................................................................................................... 272 7.2.1.5.5Recent Developments ............................................................................................ 274 7.2.1.5.6SWOT Analysis ...................................................................................................... 274 7.2.1.6 IXICO plc ......................................................................................................... 276 7.2.1.6.1Company Overview ................................................................................................ 276 7.2.1.6.2Role of IXICO plc in the Global Digital Biomarkers Market ................................... 276 7.2.1.6.3Product Portfolio and Offerings .............................................................................. 277 7.2.1.6.4Financials ............................................................................................................... 278 7.2.1.6.5Recent Developments ............................................................................................ 279 7.2.1.6.6SWOT Analysis ...................................................................................................... 280 7.2.1.7 Koninklijke Philips N.V. .................................................................................... 281 7.2.1.7.1Company Overview ................................................................................................ 281 7.2.1.7.2Role of Koninklijke Philips N.V. in the Global Digital Biomarkers Market .............. 281 7.2.1.7.3Product Portfolio and Offerings .............................................................................. 281 All rights reserved at BIS Research Inc. 16

  17. 7.2.1.7.4Financials ............................................................................................................... 282 7.2.1.7.4.1Koninklijke Philips N.V.: SWOT Analysis ........................................................ 284 7.2.1.8 Shimmer .......................................................................................................... 286 7.2.1.8.1Company Overview ................................................................................................ 286 7.2.1.8.2Role of Shimmer in the Global Digital Biomarkers Market .................................... 286 7.2.1.8.3Product Portfolio and Offerings .............................................................................. 287 7.2.1.8.3.1Recent Developments .................................................................................... 287 7.2.1.8.4SWOT Analysis ...................................................................................................... 288 7.2.1.9 Quanterix Corporation ..................................................................................... 289 7.2.1.9.1Company Overview ................................................................................................ 289 7.2.1.9.2Role of Quanterix Corporation in the Global Digital Biomarkers Market ............... 289 7.2.1.9.3Product Portfolio and Offerings .............................................................................. 289 7.2.1.9.4Financials ............................................................................................................... 290 7.2.1.9.5Recent Developments ............................................................................................ 292 7.2.1.9.6SWOT Analysis ...................................................................................................... 292 7.2.2Start-Ups .................................................................................................... 294 7.2.2.1 Altoida AG ........................................................................................................ 294 7.2.2.1.1Company Overview ................................................................................................ 294 7.2.2.1.2Role of Altoida AG in the Global Digital Biomarkers Market .................................. 294 7.2.2.1.3Product Portfolio and Offerings .............................................................................. 294 7.2.2.1.4Recent Developments ............................................................................................ 295 7.2.2.1.5SWOT Analysis ...................................................................................................... 295 7.2.2.2 Evidation Health, Inc. ....................................................................................... 296 7.2.2.2.1Company Overview ................................................................................................ 296 7.2.2.2.2Role of Evidation Health, Inc. in the Global Digital Biomarker Market ................... 296 7.2.2.2.3Product Portfolio and Offerings .............................................................................. 296 7.2.2.2.4Recent Developments ............................................................................................ 297 7.2.2.2.5SWOT Analysis ...................................................................................................... 297 7.2.2.3 Happify, Inc. ..................................................................................................... 298 7.2.2.3.1Company Overview ................................................................................................ 298 All rights reserved at BIS Research Inc. 17

  18. 7.2.2.3.2Role of Happify, Inc. in the Global Digital Biomarker Market ................................. 298 7.2.2.3.3Product Portfolio and Offerings .............................................................................. 298 7.2.2.3.4Recent Developments ............................................................................................ 299 7.2.2.3.5SWOT Analysis ...................................................................................................... 299 7.2.2.4 Huma ............................................................................................................... 300 7.2.2.4.1Company Overview ................................................................................................ 300 7.2.2.4.2Role of Huma in the Global Digital Biomarker Market ........................................... 300 7.2.2.4.3Product Portfolio and Offerings .............................................................................. 300 7.2.2.4.4Recent Developments ............................................................................................ 301 7.2.2.4.5SWOT Analysis ...................................................................................................... 301 7.2.2.5 Human API ...................................................................................................... 302 7.2.2.5.1Company Overview ................................................................................................ 302 7.2.2.5.2Role of Human API in the Global Digital Biomarkers Market. ............................... 302 7.2.2.5.3Product Portfolio and Offerings .............................................................................. 302 7.2.2.5.4Recent Developments ............................................................................................ 303 7.2.2.5.5SWOT Analysis ...................................................................................................... 303 7.2.2.6 Mindstrong Health ............................................................................................ 304 7.2.2.6.1Company Overview ................................................................................................ 304 7.2.2.6.2Role of Mindstrong Health in the Global Digital Biomarker Market ....................... 304 7.2.2.6.3Product Portfolio and Offerings .............................................................................. 304 7.2.2.6.4Recent Developments ............................................................................................ 305 7.2.2.6.5SWOT Analysis ...................................................................................................... 305 7.2.2.7 Neurotrack Technologies, Inc. ......................................................................... 306 7.2.2.7.1Company Overview ................................................................................................ 306 7.2.2.7.2Role of Neurotrack Technologies, Inc. in the Global Digital Biomarker Market ................................................................................................................... 306 7.2.2.7.3Product Portfolio and Offerings .............................................................................. 306 7.2.2.7.4Recent Developments ............................................................................................ 307 7.2.2.7.5SWOT Analysis ...................................................................................................... 307 7.2.2.8 Orikami ............................................................................................................ 308 All rights reserved at BIS Research Inc. 18

  19. 7.2.2.8.1Company Overview ................................................................................................ 308 7.2.2.8.2Role of Orikami in the Global Digital Biomarker Market ........................................ 308 7.2.2.8.3Product Portfolio and Offerings .............................................................................. 308 7.2.2.8.4Recent Developments ............................................................................................ 309 7.2.2.8.5SWOT Analysis ...................................................................................................... 309 7.2.2.9 Winterlight Labs Inc. ........................................................................................ 310 7.2.2.9.1Company Overview ................................................................................................ 310 7.2.2.9.2Role of Winterlight Labs, Inc. in the Global Digital Biomarkers Market ................. 310 7.2.2.9.3Product Portfolio and Offerings .............................................................................. 310 7.2.2.9.4Recent Developments ............................................................................................ 311 7.2.2.9.5SWOT Analysis ...................................................................................................... 311 All rights reserved at BIS Research Inc. 19

  20. List of Figures Figure 1: Evolution of Digital Health Figure 2: Applications of Digital Biomarkers Figure 3: Global Digital Biomarkers Market, Impact Analysis Figure 4: Global Digital Biomarkers Market Potential, $Million, 2020, 2024, and 2028 Figure 5: Global Digital Biomarkers Market (by System Components), $Million, 2021,2024 and 2028 Figure 6: Global Digital Biomarkers Market (by End User), $Million, 2019-2028 Figure 7: Global Digital Biomarker Market, Key Developments and Strategies, January 2017-December 2021 Figure 8: Growth-Share Matrix of the Global Digital Biomarkers Market, 2021-2028 Figure 9: Global Digital Biomarkers Market Segmentation Figure 10: Global Digital Biomarkers Market: Research Methodology Figure 11: Primary Research Figure 12: Secondary Research Figure 13: Data Triangulation Figure 14: Global Digital Biomarkers Market Research Process Figure 15: Assumptions and Limitations Figure 16: Global Digital Biomarkers Market, Realistic Growth Scenario, $Million, 2019-2028 Figure 17: Global Digital Biomarkers Market, Optimistic Growth Scenario, $Million, 2019-2028 Figure 18: Global Digital Biomarkers Market, Pessimistic Growth Scenario, $Million, 2019-2028 Figure 19: Digital Biomarkers Ecosystem Figure 20: Workflow of Digital Health Tools Figure 21: Global Digital Biomarkers Market, Short-Term Growth Potential, $Million, 2022-2025 Figure 22: Global Digital Biomarkers Market, Long-Term Growth Potential, $Million, 2026-2028 Figure 23: Global Digital Biomarkers Market, Product Benchmarking Figure 24: Global Digital Biomarkers Market, Patent Publication Growth Trend, January 2019-December 2021 Figure 25: Global Digital Biomarkers Market, Patent Filing Trend (by Country/Cluster), January 2019- December 2021 Figure 26: Applications of Wearables in COVID-19 Figure 27: Digital Biomarkers and COVID-19 Pandemic Figure 28: Global Digital Biomarkers Market Pre-COVID-19 Scenario, $Million, 2020-2028 All rights reserved at BIS Research Inc. 20

  21. Figure 29: Global Digital Biomarkers Market Y-o-Y Growth Comparative Analysis (With COVID-19 Vs. Without COVID-19) Figure 30: Impact Trends and Scenarios During COVID-19 (by Region), 2020-2021 Figure 31: Global Digital Biomarkers Market, Impact Analysis Figure 32: Process of Transmission of Data in Digital Biomarkers Figure 33: Healthcare Interoperability Challenges Figure 34: Global Digital Biomarkers Market (by Application) Figure 35: Global Digital Biomarkers Market Incremental Opportunity (by Application), $Million, 2022- 2028 Figure 36: Global Digital Biomarkers Market, Growth-Share Matrix (by Application), 2021-2028 Figure 37: Global Digital Biomarkers Market (Gastrointestinal Diseases), $Million, 2019-2028 Figure 38: Global Digital Biomarkers Market (Sleep and Movement Disorders), $Million, 2019-2028 Figure 39: Global Digital Biomarkers Market (Cardiovascular), $Million, 2019-2028 Figure 40: Global Digital Biomarkers Market (Psychiatric Disorders (Mood and Behavior)), $Million, 2019- 2028 Figure 41: Global Digital Biomarkers Market (Chronic Pain), $Million, 2019-2028 Figure 42: Global Digital Biomarkers Market (Neurodegenerative Disorders), $Million, 2019-2028 Figure 43: Global Digital Biomarkers Market (Diabetes), $Million, 2019-2028 Figure 44: Global Digital Biomarkers Market (Respiratory Diseases), $Million, 2019-2028 Figure 45: Global Digital Biomarkers Market (Others), $Million, 2019-2028 Figure 46: Global Digital Biomarkers Market (by End User) Figure 47: Global Digital Biomarkers Market Incremental Opportunity (by End User), $Million, 2022-2028 Figure 48: Global Digital Biomarkers Market, Growth-Share Matrix (by End User), 2021e-2028 Figure 49: Global Digital Biomarkers Market (Biopharmaceutical Companies), $Million, 2019-2028 Figure 50: Global Digital Biomarkers Market (Payers), $Million, 2019-2028 Figure 51: Global Digital Biomarkers Market (Providers), $Million, 2019-2028 Figure 52: Global Digital Biomarkers Market (by System Components) Figure 53: Global Digital Biomarkers Market Incremental Opportunity (by Product Type), $Million, 2022- 2028 Figure 54: Market Share Analysis (by System Components), $Million, 2021 Figure 55: Global Digital Biomarkers Market, Growth-Share Matrix (by System Components), 2021-2028 Figure 56: Global Digital Biomarker Data Collection Tools Market, $Million, 2019-2028 Figure 57: Applications of Healthcare Wearables Figure 58: Number of Clinical Trials Using Connected Wearable Devices (by Year) (Cumulative) All rights reserved at BIS Research Inc. 21

  22. Figure 59: Global Digital Biomarkers Market (Wearable Devices), $Million, 2019-2028 Figure 60: Global Digital Biomarkers Market (Implantables), $Million, 2019-2028 Figure 61: Benefits of mHealth Figure 62: Global Digital Biomarkers Market (Mobile Applications), $Million, 2019-2028 Figure 63: Process of Data Integration in Remote Patient Monitoring (RPM) Figure 64: Global Digital Biomarkers Market (Data Integration Software), $Million, 2019-2028 Figure 65: Global Digital Biomarkers Market (by Type) Figure 66: Global Digital Biomarkers Market Incremental Opportunity (by Type), $Million, 2022-2028 Figure 67: Market Share Analysis (by System Components), $Million, 2021 Figure 68: Global Digital Biomarkers Market, Growth-Share Matrix (by Type), 2021-2028 Figure 69: Global Digital Biomarkers Market (Clinical Trials), $Million, 2019-2028 Figure 70: Global Digital Biomarkers Market (Clinical Settings), $Million, 2019-2028 Figure 71: North America Digital Biomarkers Market Incremental Growth Opportunity (by Country), $Million, 2022-2028 Figure 72: North America Digital Biomarkers Market, $Million, 2019-2028 Figure 73: North America Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 74: North America Digital Biomarkers Market (By Type), $Million, 2019-2028 Figure 75: U.S. Digital Biomarkers Market, $Million, 2019-2028 Figure 76: U.S. Digital Biomarkers Market (by Product Type), $Million, 2019-2028 Figure 77: U.S. Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 78: Canada Digital Biomarkers Market, $Million, 2019-2028 Figure 79: Canada Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 80: Canada Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 81: Europe Digital Biomarkers Market Incremental Growth Opportunity (by Country), $Million, 2022-2028 Figure 82: Europe Digital Biomarkers Market, $Million, 2019-2028 Figure 83: Europe Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 84: Europe Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 85: Netherlands Digital Biomarkers Market, $Million, 2019-2028 Figure 86: Netherlands Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 87: Netherlands Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 88: Germany Digital Biomarkers Market, $Million, 2019-2028 Figure 89: Germany Digital Biomarkers Market (by Type), $Million, 2019-2028 All rights reserved at BIS Research Inc. 22

  23. Figure 90: Germany Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 91: France Digital Biomarkers Market, $Million, 2019-2028 Figure 92: France Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 93: France Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 94: Italy Digital Biomarkers Market, $Million, 2019-2028 Figure 95: Italy Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 96: Italy Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 97: Spain Digital Biomarkers Market, $Million, 2019-2028 Figure 98: Spain Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 99: Spain Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 100:Russia Digital Biomarkers Market, $Million, 2019-2028 Figure 101:Russia Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 102:Russia Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 103:U.K. Digital Biomarkers Market, $Million, 2019-2028 Figure 104:U.K. Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 105:U.K. Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 106:Rest-of-Europe Digital Biomarkers Market, $Million, 2019-2028 Figure 107:Rest-of-Europe Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 108:Rest-of-Europe Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 109:Asia-Pacific Digital Biomarkers Market Incremental Growth Opportunity (by Country), $Million, 2022-2028 Figure 110:Asia-Pacific Digital Biomarkers Market, $Million, 2019-2028 Figure 111:Asia-Pacific Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 112:Asia-Pacific Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 113:Singapore Digital Biomarkers Market, $Million, 2019-2028 Figure 114:Singapore Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 115:Singapore Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 116:Australia Digital Biomarkers Market, $Million, 2019-2028 Figure 117:Australia Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 118:Australia Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 119:India Digital Biomarkers Market, $Million, 2019-2028 Figure 120:India Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 121:India Digital Biomarkers Market (by Application), $Million, 2019-2028 All rights reserved at BIS Research Inc. 23

  24. Figure 122:South Korea Digital Biomarkers Market, $Million, 2019-2028 Figure 123:South Korea Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 124:South Korea Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 125:Japan Digital Biomarkers market, $Million, 2019-2028 Figure 126:Japan Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 127:Japan Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 128:China Digital Biomarkers Market, $Million, 2019-2028 Figure 129:China Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 130:China Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 131:Rest-of-Asia-Pacific Digital Biomarkers Market, $Million, 2019-2028 Figure 132:Rest-of-Asia-Pacific Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 133:Rest-of-Asia-Pacific Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 134:Latin America Digital Biomarkers Market Incremental Growth Opportunity (by Country), $Million, 2022-2028 Figure 135:Latin America Digital Biomarkers Market, $Million, 2019-2028 Figure 136:Latin America Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 137:Latin America Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 138:Brazil Digital Biomarkers Market, $Million, 2019-2028 Figure 139:Brazil Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 140:Brazil Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 141:Mexico Digital Biomarkers Market, $Million, 2019-2028 Figure 142:Mexico Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 143:Mexico Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 144:Rest-of-Latin America Digital Biomarkers Market, $Million, 2019-2028 Figure 145:Rest-of-Latin America Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 146:Rest-of-Latin America Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 147:Rest-of-the-World Digital Biomarkers Market Regulations Figure 148:Rest-of-the-World Digital Biomarkers Market Incremental Growth Opportunity (by Country), $Million, 2022-2028 Figure 149:Rest-of-the-World Digital Biomarkers market, $Million, 2019-2028 Figure 150:Rest-of-the-World Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 151:Rest-of-the-World Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 152:Saudi Arabia Digital Biomarkers Market, $Million, 2019-2028 All rights reserved at BIS Research Inc. 24

  25. Figure 153:Saudi Arabia Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 154:Saudi Arabia Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 155:U.A.E. Digital Biomarkers Market, $Million, 2019-2028 Figure 156:U.A.E. Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 157:U.A.E. Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 158:Israel Digital Biomarkers Market, $Million, 2019-2028 Figure 159:Israel Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 160:Israel Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 161:South Africa Digital Biomarkers Market, $Million, 2019-2028 Figure 162:South Africa Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 163:South Africa Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 164:Rest-of-Rest-of-the-World Digital Biomarkers Market, $Million, 2019-2028 Figure 165:Rest-of-Rest-of-the-World Digital Biomarkers Market (by Type), $Million, 2019-2028 Figure 166:Rest-of-Rest-of-the-World Digital Biomarkers Market (by Application), $Million, 2019-2028 Figure 167:Global Digital Biomarkers Market, Key Developments, January 2017-February 2022 Figure 168:Partnerships, Alliances, and Business Expansions Share (by Company), January 2017- February 2022 Figure 169:Funding Activities (by Company), January 2017-February 2022 Figure 170:New Product Offerings and Upgradations Share (by Company), January 2017-February 2022 Figure 171:Mergers and Acquisitions (by Company), January 2017-February 2022 Figure 172:Regulatory and Legal Activities Share (by Company), January 2017-February 2022 Figure 173:Alphabet Inc.: Overall Product Portfolio Figure 174:Alphabet Inc.: Overall Financials, $Million, 2019-2021 Figure 175:Alphabet Inc.: R&D Expenditure, $Million, 2019-2021 Figure 176:Alphabet Inc.: Revenue (by Region), $Million, 2019-2021 Figure 177:AliveCor, Inc: Overall Product Portfolio Figure 178:Akili Interactive Labs: Overall Product Portfolio Figure 179:Cambridge Cognition Ltd.: Overall Product Portfolio Figure 180:Cambridge Cognition Ltd: Overall Financials, $Million, 2018-2020 Figure 181:Cambridge Cognition Ltd: Net Revenue (by Segment), $Million, 2018-2020 Figure 182:Cambridge Cognition Ltd: Net Revenue (by Region), $Million, 2018-2020 Figure 183:Cambridge Cognition Ltd: R&D Expenditure, $Million, 2018-2020 Figure 184:Dassault Systèmes: Overall Product Portfolio All rights reserved at BIS Research Inc. 25

  26. Figure 185:Dassault Systèmes: Overall Financials, $Million, 2018-2020 Figure 186:Dassault Systèmes: Net Revenue (by Segment), $Million, 2018-2020 Figure 187:Dassault Systèmes: Net Revenue (by Region), $Million, 2018-2020 Figure 188:Dassault Systèmes: R&D Expenditure, $Million, 2019-2021 Figure 189:IXICO plc: Overall Product Portfolio Figure 190:IXICO plc: Overall Financials, $Million, 2019-2021 Figure 191:IXICO plc: R&D Expenditure, $Million, 2019-2021 Figure 192:IXICO plc: Revenue (by Region), $Million, 2020-2021 Figure 193:Koninklijke Philips N.V.: Overall Product Portfolio Figure 194:Koninklijke Philips N.V.: Overall Financials, $Million, 2019-2021 Figure 195:Koninklijke Philips N.V.: Net Revenue (by Segment), $Million, 2019-2021 Figure 196:Koninklijke Philips N.V.: Net Revenue (by Region), $Million, 2019-2021 Figure 197:Koninklijke Philips N.V.: R&D Expenditure, $Million, 2019-2021 Figure 198:Shimmer: Overall Product Portfolio Figure 199:Quanterix Corporation: Overall Product Portfolio Figure 200:Quanterix Corporation: Overall Financials, $Million, 2018-2020 Figure 201:Quanterix Corporation: Net Revenue (by Segment), $Million, 2018-2020 Figure 202:Quanterix Corporation: Net Revenue (by Region), $Million, 2018-2020 Figure 203:Quanterix Corporation: R&D Expenditure, $Million, 2018-2020 Figure 204:Altoida, AG: Overall Product Portfolio Figure 205:Evidation Health, Inc.: Overall Product Portfolio Figure 206:Happify, Inc.: Overall Product Portfolio Figure 207:Huma: Overall Product Portfolio Figure 208:Human API: Overall Product Portfolio Figure 209:Mindstrong Health: Overall Product Portfolio Figure 210:Neurotrack Technologies, Inc.: Overall Product Portfolio Figure 211:Orikami: Overall Product Portfolio Figure 212:Winterlight Labs, Inc.: Overall Product Portfolio All rights reserved at BIS Research Inc. 26

  27. List of Tables Table 1: Challenges in the Global Digital Biomarkers Market Table 2: Global Digital Biomarkers: Key Trends Table 3: Awaited Technological Developments in the Global Digital Biomarkers Market Table 4: Summary Of Research Studies Performed on Screening, Tracking, and Prevention of COVID- 19 Table 5: Features of Major Wearable Devices Table 6: Global Digital Biomarkers Market, Major FDA Clearances, 2022 Table 7: Commercially Available Mobile Applications Used for Monitoring and Managing Inflammatory Bowel’s Disease Table 8: Key Developments in the Gastrointestinal Diseases Space Using Digital Health Table 9: Key Developments in Sleep and Movement Disorders Using Digital Health Table 10: Key Developments in Cardiovascular Diseases Space Using Digital Health Table 11: Key Developments in the Mood-Related Disorders Space Using Digital Health Table 12: Key Developments in Chronic Pain Space Using Digital Health Table 13: Key Developments in Neurodegenerative Disorders Space Using Digital Health Table 14: Key Developments in Diabetes Space Using Digital Health Table 15: Leading Respiratory Conditions and its Incidence (in Million) Table 16: Key Developments in Respiratory Diseases Space Using Digital Health Table 17: Commercial Products Available, Implantable Devices Table 18: North America Digital Biomarkers Market: Regulatory Framework Table 19: North America Digital Biomarkers Market, Impact Analysis Table 20: Europe Digital Biomarkers Market Regulatory Framework Table 21: Challenges in MDR Implementation Table 22: Europe Digital Biomarkers Market, Impact Analysis Table 23: Asia-Pacific Digital Biomarkers Market Regulatory Framework Table 24: Asia-Pacific Digital Biomarkers Market, Impact Analysis Table 25: Latin America Digital Biomarkers Market Regulations Table 26: Latin America Digital Biomarkers Market, Impact Analysis Table 27: Rest-of-the-World Digital Biomarkers Market, Impact Analysis All rights reserved at BIS Research Inc. 27

  28. BIS Research Offerings: We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s digital age. We have a vision to be a leading and a preferred knowledge partner for corporates and institutions worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other innovative solutions. Know More Know More Know More Know More All rights reserved at BIS Research Inc. 28

  29. Disclaimer BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published, or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings. Market reports are based on expectations, estimates, and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties, and contingencies For more details regarding permission, please contact us: Email: sales@bisresearch.com Tel: +1 510 404 8135 All rights reserved at BIS Research Inc. 29

  30. BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135 Global Delivery Center Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540 / 4261544 All rights reserved at BIS Research Inc. 30 www.bisresearch.com

More Related